Artigo Acesso aberto Revisado por pares

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

2013; Elsevier BV; Volume: 121; Issue: 14 Linguagem: Inglês

10.1182/blood-2012-11-466037

ISSN

1528-0020

Autores

Pratap Neelakantan, Gareth Gerrard, Claire Lucas, Dragana Milojković, Philippa C. May, Lihui Wang, Christos Paliompeis, Marco Bua, Alistair Reid, Katayoun Rezvani, Stephen J. O’Brien, Richard E. Clark, John M. Goldman, David Marin,

Tópico(s)

Acute Lymphoblastic Leukemia research

Resumo

Key Points Response to TKIs can be accurately established by measuring the 3-month transcript level. An additional measurement of the transcript level at 6 months adds very little useful clinical information to the 3-month result.

Referência(s)